Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply. (26th February 2019)

Record Type:: Journal Article
Title:: Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply. (26th February 2019)
Main Title:: Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply
Authors:: Sircar, Geetabali
Goswami, Rudra Prosad
Sircar, Dipankar
Ghosh, Alakendu
Ghosh, Parasar
Abstract:
Is Part Of:: Rheumatology. Volume 58:Number 5(2019)
Journal:: Rheumatology
Issue:: Volume 58:Number 5(2019)
Issue Display:: Volume 58, Issue 5 (2019)
Year:: 2019
Volume:: 58
Issue:: 5
Issue Sort Value:: 2019-0058-0005-0000
Page Start:: 925
Page End:: 926
Publication Date:: 2019-02-26
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/kez054 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11988.xml